Andy Baxter
Drug Development Advisor
In a career spanning over 30 years, Andy has held senior technical and management positions in major pharmaceutical companies, emerging biotech companies, and most recently, small virtual pharmaceutical companies including Glaxo Group Research, Pfizer, Chiroscience-Celltech, Arakis-Sosei, Serentis and Altacor.
Andy has in-depth experience of the drug discovery and development process, leading programs from lead generated into clinical trials. Andy has many years of experience managing development programs and has broad technical and quality understanding of preclinical, chemistry, manufacturing and controls (CMC), regulatory and early clinical operations.
